Breaking News

SNBL Appoints Safety Assessment Director

January 10, 2013

Glaza brings 30 years of lab experience

Steve Glaza has been appointed director of safety assessment at SNBL USA. Mr. Glaza joins the leadership team and is responsible for all facets of the safety assessment department, managing day-to-day operations to ensure continued operational and scientific excellence. In addition, he will work with the executive management team in formulating and directing current and long-range plans, objectives and policies to support sponsors with compliance and efficiency.
 
Prior to joining the company, Mr. Glaza spent 30 years at Covance Laboratories. He began as a group leader in the toxicology department and moved up the ranks to manager/study director, then associate director of formulations and associate director of toxicology/safety assessment. He became the site manager for the dedicated client facility, taking the position of associate director and site scientific lead of safety assessment.
 
“We are very excited to have Steve join SNBL USA,” said Dr. Thomas Beck, SNBL USA president and chief operating officer. “His wealth of experience in the CRO industry makes him an ideal team leader to successfully synchronize industry regulations and compliance with client expectations."
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Consolidation in Outsourcing

    Consolidation in Outsourcing

    Michael A. Martorelli, Fairmount Partners||March 9, 2016
    Reviewing 2015’s M&A activity

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.